Kodiak Sciences Stock Is Surging Friday: What's Driving The Action?
Kodiak Sciences Inc (NASDAQ: KOD ) shares are trading higher Friday morning after the company announced positive topline results from its Phase 3 GLOW2 study for Zenkuda in diabetic retinopathy, hitting a new 52-week high in early trading. Investors appear to be responding to both the strength of the data and the possibility of a faster path toward a biologics license application, or BLA. Here’s what investors need to know . Kodiak Sciences stock is challenging resistance. Why are KOD shares at highs? Zenkuda Hits Primary, Secondary Endpoints In GLOW2 In the GLOW2 ... Full story available on Benzinga.com
